Consistent with this, the expression of ICAM-1 is negatively correlated with the incidence of lymph node or distant metastasis in patients with breast cancer and colorectal cancer (54, 55), suggesting a favorable prognosis. Here, ICAM1 is linked to colorectal cancer.